Building a future-ready, innovative healthcare industry
India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care
Kiran Mazumdar-Shaw - August 28, 2020
Kiran Mazumdar Shaw’s multi-billion dollar baby
Biocon Biologics’ valuation has raised eyebrows. But the parent has strong growth on its side and a track record of solid execution
Kripa Mahalingam - April 25, 2020
How Biocon has been leading from the front | Editor's Note
Kiran Mazumdar Shaw's bold biologics bet is set to reap rewards
N Mahalakshmi - April 25, 2020
How India Inc is countering coronavirus | Editor's note
Top India Inc honchos share their insights on what needs to be done
N Mahalakshmi - April 16, 2020
Biocon's Kiran Mazumdar Shaw's prescription for fighting COVID-19
Biocon CMD shares her insights on how Indian biotech industry can leverage the coronavirus crisis and turn it into a massive opportunity
Hari Menon - April 11, 2020
The Outperformers (41-50)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
August 28, 2019
The Keymakers
With a powerful client base and an all-in-one package, the contract R&D firm Syngene is galloping ahead and now even into manufacturing
Shruti Venkatesh - May 17, 2019
“When learning is through association, you never really forget anything”
Secret Diary Of Kiran Mazumdar – Part 1
Kripa Mahalingam - May 08, 2018
“Failure is temporary but giving up is permanent”
Secret Diary Of Kiran Mazumdar – Part 2
Kripa Mahalingam - May 08, 2018
Skilling for Life
The Nudge Foundation through its focused skill development programme is helping the underprivileged find the right jobs
Shilpa Elizabeth Abraham - October 03, 2017
